Aethlon Medical Stock News

Are these penny stocks on your watchlist right now? The post Check These 3 Penny Stocks Out For Your Watchlist  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Are these penny stocks on your watchlist right now? The post Check These 3 Penny Stocks Out For Your Watchlist  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Monkeypox stocks to watch today. The post Penny Stocks To Buy Now? Hot Monkeypox Stocks To Watch Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Monkeypox stocks to watch today. The post Penny Stocks To Buy Now?

SAN DIEGO, May 17, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, tod

Aethlon Medical press release (NASDAQ:AEMD): FQ3 GAAP EPS of -$0.16 misses by $0.02.Revenue of $0.02M (-96.8% Y/Y) misses by $0.19M.

Aethlon Medical's (AEMD) CEO Chuck Fisher on Q3 2022 Results - Earnings Call Transcript

Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate

Aethlon Medical (NASDAQ:AEMD) is scheduled to announce Q3 earnings results on Monday, February 14th, after market close.The consensus EPS Estimate is -$0.14 (+30.0% Y/Y) and the

DUBLIN , Feb. 7, 2022 /PRNewswire/ -- The "Global Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange Device), Portability (Portable, Stationary), Indication, End User, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com''s offering. The global blood purification equipment market will reach $21.08 billion by 2031, growing by 5.5% annually over 2021-2031, driven by the increasing prevalence of blood-related diseases, rising geriatric population, technological innovations, growing healthcare expenditure, rising adoption of home based healthcare, and the rising health consciousness amid COVID-19 pandemic. This report is based on a comprehensive research of the entire global blood purification equipment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.

SAN DIEGO, Jan. 31, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it

Longview Acquisition Corp. II (NYSE:LGV) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, institutional ownership and risk. Analyst Ratings This is a breakdown of current recommendations and price targets for []

Wall Street analysts expect Aethlon Medical, Inc. (NASDAQ:AEMD) to report earnings per share (EPS) of ($0.13) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Aethlon Medicals earnings. Aethlon Medical reported earnings of ($0.20) per share in the same quarter last year, which suggests a positive year-over-year growth []

Wall Street analysts expect that Aethlon Medical, Inc. (NASDAQ:AEMD) will announce $260,000.00 in sales for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Aethlon Medicals earnings. The highest sales estimate is $400,000.00 and the lowest is $110,000.00. Aethlon Medical reported sales of $630,000.00 in the same quarter last year, which []